课题基金 / 基金详情

Protein Kinase Signaling and Cell Cycle Control

Protein Kinase Signaling and Cell Cycle Control
蛋白激酶信号传导和细胞周期控制
批准号:
7317352
负责人:
MICHAEL B YAFFE
金额:
$35.3万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2011-11-30

项目摘要

项目成果

MICHAEL B YAFFE的其他基金

相似基金

相关文献

中文摘要
翻译
我们实验室的长期目标是在分子细节上了解蛋白激酶信号如何 信号通路与磷酸丝氨酸/苏氨酸结合区一起调节细胞的多个方面 增殖,包括细胞周期进程和细胞对DMAdamage的反应。在现在 建议,我们探索MAPKAP Kinase-2的功能,MAPKAP Kinase-2是一种由p38激活的应激反应蛋白激酶 MARK作为S期和有丝分裂进程的关键调节者,对环境和环境的响应 内源性DMA损伤类型。我们使用广泛的生物化学和分子细胞的组合 生物学探讨DMA后MAPKAP-2激活的信号转导机制 化学物质和UV-C辐射引起的损伤,并研究MAPKAP Kinase-2如何共同发挥作用 与Chk1等其他检查点激酶一起,控制细胞在遗传毒性应激后的细胞周期进程 文化。我们继续开发有条件的MAPKAP Kinase-2基因敲除小鼠,以探索 在基因定义的肉瘤和肺模型中MAPKAP Kinase-2作为肿瘤抑制因子发挥作用 癌症,以及环境致癌物诱导的结直肠癌和皮肤癌模型。最后,我们探索 MAPKAP Kinase-2下调是否促进化学诱导DNA损伤后的细胞死亡 像化疗这样的损害。 这些研究应该澄清来自p38 MAPK-MAPKAP Kinase-2通路的信号是如何通过一种全球应激- 响应网络,由各种各样的有毒侮辱激活,与来自专用的 DNA损伤反应通路,调节细胞对遗传毒性应激的反应。评选结果 拟议的实验应该揭示MAPKAP Kinase-2是否作为一种肿瘤抑制基因发挥作用 调节暴露于环境制剂后的癌症风险,以及是否有特定的靶向 MAPKAP Kinase-2对增敏肿瘤细胞毒作用具有治疗价值 常规化疗。
英文摘要
The long-term goal of our laboratory is to understand, in molecular detail, how protein kinase signaling pathways together with phosphoserine/threonine-binding domains regulate multiple aspects of cell proliferation, including cell cycle progression and the cellular response to DMAdamage. In the present proposal, we explore the function of MAPKAP Kinase-2, a stress-responsive protein kinase activated by p38 MARK, as a critical regulator of S-phase and mitotic progression in response to environmental and endogenous types of DMA damage. We use a combination of extensive biochemistry and molecular cell biology to explore the signal transduction mechanisms involved in MAPKAP Kinase-2 activation after DMA damage induced by chemicals and UV-C irradiation, and examine how MAPKAP Kinase-2 functions together with other checkpoint kinases such as Chk1, to control cell cycle progression after genotoxic stress in cells in culture. We go on to develop a conditional MAPKAP Kinase-2 knock-out mouse to explore whether MAPKAP Kinase-2 functions as a tumor suppressor in genetically defined models of sarcoma and lung cancer, and in environmental carcinogen-induced models of colorectal and skin cancer. Finally, we explore whether down-regulation of MAPKAP Kinase-2 facilitates cell death after intentional chemically-induced DNA damage such as chemotherapy. These studies should clarify how signals from the p38 MAPK-MAPKAP Kinase-2 pathway, a global stress- responsive network that is activated by a wide variety of toxic insults, integrate with those from dedicated DNA damage response pathways,to regulate the cellular response to genotoxic stress. The results of the proposed experiments should reveal whether MAPKAP Kinase-2 functions as a tumor suppressor gene that modulates the risk of cancer after exposure to environmental agents, and whether specific targeting of MAPKAP Kinase-2 would be of therapeutic value for sensitizing tumors to the cytotoxic effects of conventional chemotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Kinase Signaling in the Genotoxic Stress Response
Protein Kinase Signaling in the Genotoxic Stress Response
Protein Kinase Signaling in the Genotoxic Stress Response
Protein Kinase Signaling in the Genotoxic Stress Response
海外基金